Health Care REIT Inc. (HCN), a real estate investment trust (REIT) that operates senior housing and health care real estate assets, has recently announced plans to offer 9.0 million common shares to raise cash. The company will also grant the underwriters an option to purchase an additional 1.4 million shares to cover any over-allotments.
Health Care REIT expects to utilize the proceeds for acquisitions due to distressed selling by property owners who have not been able to refinance their assets. The company also expects to utilize a part of the proceeds to repay debt. BofA Merrill Lynch, the investment banking and wealth management division of Bank of America Corporation (BAC); J.P. Morgan Securities LLC, the investment banking division of JPMorgan Chase & Co. (JPM); and UBS Investment Bank, the investment banking division of UBS AG (UBS) are acting as joint book-running managers for the offering.
Health Care REIT invests across the full spectrum of senior housing and healthcare real estate properties. Headquartered in Toledo, Ohio, the company also provides an extensive array of property management and development services.
Founded in 1970, the company was the first REIT to invest exclusively in healthcare facilities. Health Care REIT provides senior housing operators and healthcare systems with a single source for facility planning, design and turn-key development, property management, and monetization or expansion of existing real estate.
However, deep cuts in Medicare have been proposed over the next five years by reducing or freezing payments to skilled nursing facilities, hospitals, and other healthcare providers. With a large portion of revenues being determined by government payout rates, forces beyond the company's control could negatively affect revenues and operator coverage ratios. Consequently, we maintain our ‘Neutral' recommendation on Health Care REIT, which currently has a Zacks #3 Rank that indicates a short-term ‘Hold' rating.
BANK OF AMER CP (BAC): Free Stock Analysis Report
HEALTH CR REIT (HCN): Free Stock Analysis Report
JPMORGAN CHASE (JPM): Free Stock Analysis Report
UBS AG (UBS): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.